Transcend Capital Advisors LLC cut its position in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) by 3.3% during the 4th quarter, Holdings Channel reports. The firm owned 69,102 shares of the company’s stock after selling 2,378 shares during the period. Transcend Capital Advisors LLC’s holdings in iShares U.S. Medical Devices ETF were worth $4,032,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of IHI. JPMorgan Chase & Co. raised its holdings in shares of iShares U.S. Medical Devices ETF by 127.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,202,394 shares of the company’s stock worth $71,206,000 after purchasing an additional 674,168 shares in the last quarter. International Assets Investment Management LLC grew its position in iShares U.S. Medical Devices ETF by 5,167.0% in the third quarter. International Assets Investment Management LLC now owns 758,814 shares of the company’s stock worth $44,937,000 after buying an additional 744,407 shares during the last quarter. Raymond James & Associates increased its holdings in shares of iShares U.S. Medical Devices ETF by 0.5% in the third quarter. Raymond James & Associates now owns 378,727 shares of the company’s stock valued at $22,428,000 after buying an additional 1,756 shares in the last quarter. Wharton Business Group LLC increased its holdings in shares of iShares U.S. Medical Devices ETF by 3.0% in the third quarter. Wharton Business Group LLC now owns 276,850 shares of the company’s stock valued at $16,395,000 after buying an additional 8,070 shares in the last quarter. Finally, Baltimore Washington Financial Advisors Inc. lifted its position in shares of iShares U.S. Medical Devices ETF by 3.1% during the 3rd quarter. Baltimore Washington Financial Advisors Inc. now owns 272,425 shares of the company’s stock valued at $16,133,000 after acquiring an additional 8,199 shares during the last quarter.
iShares U.S. Medical Devices ETF Stock Performance
NYSEARCA IHI opened at $64.84 on Friday. The stock’s 50-day moving average price is $61.65 and its two-hundred day moving average price is $59.84. iShares U.S. Medical Devices ETF has a 1 year low of $53.72 and a 1 year high of $65.18. The company has a market cap of $6.13 billion, a PE ratio of 35.18 and a beta of 0.83.
iShares U.S. Medical Devices ETF Profile
The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.
Read More
- Five stocks we like better than iShares U.S. Medical Devices ETF
- Find and Profitably Trade Stocks at 52-Week Lows
- These 3 Defensive Retail Stocks Are Outpacing the Market
- What is a buyback in stocks? A comprehensive guide for investors
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is the Nasdaq? Complete Overview with History
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report).
Receive News & Ratings for iShares U.S. Medical Devices ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Medical Devices ETF and related companies with MarketBeat.com's FREE daily email newsletter.